AKOYA BIOSCIENCES INC's ticker is AKYA and the CUSIP is 00974H104. A total of 74 filers reported holding AKOYA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 2.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $88,680 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,104,785 | $24,731,000 | 9.98% |
| Hudson Executive Capital LP | 3,697,558 | $43,446,000 | 6.22% |
| Altium Capital Management LP | 296,000 | $3,478,000 | 1.28% |
| Board of Trustees of The Leland Stanford Junior University | 774,116 | $9,096,000 | 0.58% |
| Parkman Healthcare Partners LLC | 161,701 | $1,900,000 | 0.54% |
| CLARK ESTATES INC/NY | 171,976 | $2,021,000 | 0.45% |
| Granahan Investment Management | 398,824 | $4,686,000 | 0.15% |
| Uniplan Investment Counsel, Inc. | 167,709 | $1,970,000 | 0.15% |
| RTW INVESTMENTS, LP | 483,815 | $5,685,000 | 0.13% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 126,131 | $1,482,000 | 0.11% |